United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - furosemide - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - propranolol hydrochloride - oral tablet - 40mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - furosemide - oral tablet - 40mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

relonchem ltd - gliclazide - oral tablet - 80mg

United States - English - NLM (National Library of Medicine)

aiping pharmaceutical - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. acarbose tablets are contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.

United States - English - NLM (National Library of Medicine)

modavar pharmaceuticals llc - glyburide (unii: sx6k58tvwc) (glyburide - unii:sx6k58tvwc) - glyburide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. glyburide tablets are contraindicated in patients with: 1. known hypersensitivity or allergy to the drug. 2. diabetic ketoacidosis, with or without coma. this condition should be treated with insulin. 3. type i diabetes mellitus. 4. concomitant administration of bosentan.

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - rhenium sulphide - kit for radiopharmaceutical preparation - milligram - technetium (99mtc), particles and colloids

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - sodium oxidronate - kit for radiopharmaceutical preparation - 3.0 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) oxidronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

cyclomedica ireland ltd - graphites - kit for radiopharmaceutical preparation - 1.340 gram(s) - technetium (99mtc), inhalants; technetium (99mtc) technegas

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - dimercaptosuccinic acid - kit for radiopharmaceutical preparation - 1 mg - technetium (99mtc) compounds; technetium (99mtc) succimer